Information about medicinal products published on this website is provided for informational purposes only and does not constitute advertising, a public offer, an offer for sale, or instructions for use.
The use of medicinal products is permitted only upon a doctor’s prescription. Consultations are provided by clinic specialists in person or online in accordance with applicable law.
The use of medicinal products is permitted only upon a doctor’s prescription. Consultations are provided by clinic specialists in person or online in accordance with applicable law.
DUFASTON (NETHERLANDS)
1 tablet contains 10 mg of dydrogesterone.
Dosage Form
Film-coated tablets.
The score line is intended only to facilitate swallowing and does not divide the tablet into equal doses.
Pharmacological Group
Sex hormones and modulators of the genital system. Progestogens. Pregnadiene derivatives.
Indications
Irregular menstrual cycles;
endometriosis;
dysmenorrhea;
infertility due to luteal insufficiency;
support of the luteal phase in assisted reproductive technologies (ART);
threatened and habitual miscarriage associated with progesterone deficiency.
Duphaston can be used as a cyclic addition to estrogen therapy in women with an intact uterus:
to prevent endometrial hyperplasia during menopause;
in dysfunctional uterine bleeding;
in secondary amenorrhea.
Contraindications
Undiagnosed vaginal bleeding;
existing serious liver diseases or a history of serious liver diseases if liver function indicators have not normalized;
consider contraindications for estrogens if used in combination with progestogens such as dydrogesterone;
known hypersensitivity to the active substance or any other component of the drug;
known or suspected progestogen-dependent neoplasms (e.g., meningioma).
Treatment for luteal phase support in assisted reproductive technologies (ART) should be discontinued if abortion/miscarriage is diagnosed.
The dosage, regimen, and duration of treatment are determined by the doctor.
Packaging
14 or 20 or 28 tablets in a blister pack.
Film-coated tablets.
The score line is intended only to facilitate swallowing and does not divide the tablet into equal doses.
Pharmacological Group
Sex hormones and modulators of the genital system. Progestogens. Pregnadiene derivatives.
Indications
Irregular menstrual cycles;
endometriosis;
dysmenorrhea;
infertility due to luteal insufficiency;
support of the luteal phase in assisted reproductive technologies (ART);
threatened and habitual miscarriage associated with progesterone deficiency.
Duphaston can be used as a cyclic addition to estrogen therapy in women with an intact uterus:
to prevent endometrial hyperplasia during menopause;
in dysfunctional uterine bleeding;
in secondary amenorrhea.
Contraindications
Undiagnosed vaginal bleeding;
existing serious liver diseases or a history of serious liver diseases if liver function indicators have not normalized;
consider contraindications for estrogens if used in combination with progestogens such as dydrogesterone;
known hypersensitivity to the active substance or any other component of the drug;
known or suspected progestogen-dependent neoplasms (e.g., meningioma).
Treatment for luteal phase support in assisted reproductive technologies (ART) should be discontinued if abortion/miscarriage is diagnosed.
The dosage, regimen, and duration of treatment are determined by the doctor.
Packaging
14 or 20 or 28 tablets in a blister pack.
